Publication
on the subject of Tourette syndrome
When Tourette's creative sensibility and energy are aligned, they can result in authentic works of art. Hermann Krs.mer and Gemma del Ou, although not yet personally acquainted, have already created a deep bond through their art.
Together they imagined Ticco, the dinosaur with Tourette's syndrome, a character that reflects his own life experience as they both coexist with this condition. Perhaps that's why they managed to bring him to life in such a unique way.
Fully updated: Counseling, care and treatment of children and adults with Tourette syndrome and other tic disorders
The diagnostic classification of tic disorders and differentiation from other disorders such as functional disorders as well as the assessment of available treatment options are not possible without specific knowledge.
The new edition of this standard work comprehensively conveys the current state of knowledge from science and practice on the diagnosis, differential diagnosis and treatment of Tourette syndrome and other tic disorders. Particular attention is paid to the differential diagnosis of functional tic-like movements, which have increased significantly in frequency with the onset of the COVID-19 pandemic.
Psychiatrist Prof. Dr. Dr. Kirsten Müller-Vahl, shares her clinical and research experiences.
"When I started my career, nobody was interested in tics and Tourette syndrome," she said. "You have to ask your patients a lot of questions. One of those questions is what makes your tics worse and what makes your tics better. My interest in cannabis-based medicine comes from my patients telling me, "Okay, physician." When I use cannabis, my tics really lessen.'"
She began studying the effect of cannabis on other conditions such as obsessive-compulsive disorder, attention-deficit/hyperactivity disorder (ADHD) and post-traumatic stress disorder, depression and sleep problems.
A publication about the first outbreak of a novel sociogenic mass disease that, in contrast to all previously reported episodes, is spread exclusively via social media.
More and more influencers are pretending to be Tourette's patients online. However, the signs of their disorders can be easily distinguished from symptoms of the real disease.
Randomized, double-blind, placebo-controlled study of thalamic versus GPi stimulation in patients with severe drug-refractory Gilles de la Tourette syndrome.
In the 16th edition of the book "Therapie psychischer Erkrankungen. State of the Art", the authors Prof. Dr. med. Kirsten R. Müller-Vahl and Prof. Dr. med. Irene Neuner address the topic of "Tic disorders and Tourette syndrome" in article 28.
The book can be ordered directly from the publisher. link
Production and technical realization: Florian Winterfeld
Book and text: Hermann Krämer
Music: Jean-Marc Lorber
Thanks to the Tourette-Gesellschaft Deutschland e.V.
Project by and with Tourette sufferers
The story of the dinosaur "Ticco", who has fun in life even with tics. Katto, Ticco's dad (quote): "
It may happen from time to time that you meet people who don't understand and tease you.
The important thing is that you don't question everything, yourself, your life and your future." (Author: H. Krämer)
Encouraging story for children with Tourette's.
Listen free of charge:
https://tourette-gesellschaft.de/wp-content/uploads/2020/11/ESMTS-Das-Hoerspiel.mp3
Several possibilities to listen to Ticco's story on different online platforms:
https://tourette-gesellschaft.de/ticco-ein-saurier-mit-tourette-syndrom-in-neuem-gewand/
He used to squeak, now he sings in a band
People with Tourette's syndrome emit sounds and make involuntary movements, but there are therapies
In recent years, large-scale behavioral therapy studies have initiated a trend reversal in the treatment of Gilles de la Tourette syndrome. Habit Reversal Training (HRT) in particular has proven to be effective. Based on the clinical phenomenology and neurobiological foundations of the psychotherapeutic treatment of Tourette's syndrome, with a focus on HRT, this book offers a practical manual for adults.
First patient dosed in Phase 2 trial to evaluate the efficacy of ABX-1431 in treating adult patients with Tourette Syndrome
SAN DIEGO, October 16, 2018 - Abide Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapeutics targeting the serine hydrolase family of enzymes, today announced the initiation of Phase 2 clinical development of ABX-1431, a first-in-class investigational monoacylglycerol lipase (MGLL) inhibitor, in patients with Tourette Syndrome (TS). TS is a neurodevelopmental disorder characterized by sudden, involuntary movements and vocal tics.
In this video, Tim Howard - a renowned world soccer player and former U.S. national team keeper - a celebrity who deals publicly with his Tourette's diagnosis - gives a Skype interview in the form of a question and answer session with young people who suffer from chronic tic disorders:
https://www.facebook.com/TouretteSyndrome/videos/10155467819511965/
The BBC Two documentary EMPLOYABLE ME follows people with neurological conditions such as autism, Asperger's autism, tic syndrome and Tourette's syndrome as they seek, find and develop their special skills and talents.
The uniquely positive program proves that these clinical pictures, regardless of their severity and despite their sometimes unpleasant symptoms in the public perception, do not necessarily have to be a reason for long-term unemployment. Quite the opposite: EMPLOYABLE ME shows that people with such a diagnosis can have outstanding abilities and represent real added value for employers and colleagues. Now the German version is coming to TV.
This publication details the previously announced results of the recently completed exploratory Phase 1b study in Tourette syndrome (TS) with ABX-1431, an investigational monoacylglycerol lipase (MGLL) inhibitor. In this randomized, double-blind, placebo-controlled, crossover study in adults, patients receiving a single dose of ABX-1431 consistently showed a positive impact on key TS symptoms.